New Zealand markets closed

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
42.13-0.17 (-0.40%)
As of 10:42AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
362,885
334,641
280,259
161,855
103,303
Selling general and administrative
127,485
112,624
87,589
58,243
45,813
Total operating expenses
490,370
447,265
367,848
220,098
149,116
Operating income or loss
-490,370
-447,265
-367,848
-220,098
-149,116
Interest expense
10,583
10,567
3,918
0
-
Total other income/expenses net
-8,203
-18,372
6,878
-5,393
-3,274
Income before tax
-459,912
-432,339
-351,351
-225,334
-152,166
Income tax expense
556
503
160
0
-24
Income from continuing operations
-460,468
-432,842
-351,511
-225,334
-152,142
Net income
-460,468
-432,842
-351,511
-225,334
-152,142
Net income available to common shareholders
-460,468
-432,842
-351,511
-225,334
-152,142
Basic EPS
-2.50
-
-2.32
-1.65
-2.01
Diluted EPS
-2.50
-
-2.32
-1.65
-2.01
Basic average shares
156,909
-
151,266
136,577
73,643
Diluted average shares
156,909
-
151,266
136,577
73,643